Urak R, Gittins B, Soemardy C, Grepo N, Goldberg L, Maker M, et al. Evaluation of the Elements of Short Hairpin RNAs in Developing shRNA-Containing CAR T Cells. Cancers (Basel). 2023;15: pubmed publisher

Yu J, Feng H, Sang Q, Li F, Chen M, Yu B, et al. VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer. EBioMedicine. 2023;89:104451 pubmed publisher

Yamaguchi Y, Gibson J, Ou K, Lopez L, Ng R, Leggett N, et al. PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages. J Immunother Cancer. 2022;10: pubmed publisher

Jang H, Lee H, Yu W, Ramineni M, Truong C, Ramos D, et al. Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune Microenvironment. Cancer Res. 2022;82:2593-2609 pubmed publisher

Dong C, Fu S, Karvas R, Chew B, Fischer L, Xing X, et al. A genome-wide CRISPR-Cas9 knockout screen identifies essential and growth-restricting genes in human trophoblast stem cells. Nat Commun. 2022;13:2548 pubmed publisher

Au J, Requena D, Rishik H, Kallol S, Tekkatte C, Farah O, et al. Role of autocrine bone morphogenetic protein Signaling in trophoblast stem cells. Biol Reprod. 2021;: pubmed publisher

Niu M, Xu J, Liu Y, Li Y, He T, Ding L, et al. FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth. Nat Commun. 2021;12:5919 pubmed publisher

Morey R, Farah O, Kallol S, Requena D, Meads M, Moretto Zita M, et al. Transcriptomic Drivers of Differentiation, Maturation, and Polyploidy in Human Extravillous Trophoblast. Front Cell Dev Biol. 2021;9:702046 pubmed publisher

Yerneni S, Werner S, Azambuja J, Ludwig N, Eutsey R, Aggarwal S, et al. Pneumococcal Extracellular Vesicles Modulate Host Immunity. MBio. 2021;12:e0165721 pubmed publisher

Khan S, Park K, Fischer L, Dong C, Lungjangwa T, Jimenez M, et al. Probing the signaling requirements for naive human pluripotency by high-throughput chemical screening. Cell Rep. 2021;35:109233 pubmed publisher

Horii M, Morey R, Bui T, Touma O, Nelson K, Cho H, et al. Modeling preeclampsia using human induced pluripotent stem cells. Sci Rep. 2021;11:5877 pubmed publisher

Song J, Liu Y, Liu F, Zhang L, Li G, Yuan C, et al. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway. Theranostics. 2021;11:996-1015 pubmed publisher

Sreevalsan S, Döring M, Paszkowski Rogacz M, Brux M, Blanck C, Meyer M, et al. MLLT6 maintains PD-L1 expression and mediates tumor immune resistance. EMBO Rep. 2020;:e50155 pubmed publisher

Ludwig N, Yerneni S, Azambuja J, Gillespie D, Menshikova E, Jackson E, et al. Tumor-derived exosomes promote angiogenesis via adenosine A2B receptor signaling. Angiogenesis. 2020;23:599-610 pubmed publisher

Ho J, Yang X, Nikou S, Kichik N, Donkin A, Ponde N, et al. Candidalysin activates innate epithelial immune responses via epidermal growth factor receptor. Nat Commun. 2019;10:2297 pubmed publisher

Xu X, Liu Q, Zhang C, Ren S, Xu L, Zhao Z, et al. Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence. Cell Death Dis. 2019;10:282 pubmed publisher

Dong Y, Ding Y, Guo W, Huang J, Yang Z, Zhang Y, et al. The functional verification of EGFR-CAR T-cells targeted to hypopharyngeal squamous cell carcinoma. Onco Targets Ther. 2018;11:7053-7059 pubmed publisher

Al Akhrass H, Naves T, Vincent F, Magnaudeix A, Durand K, Bertin F, et al. Sortilin limits EGFR signaling by promoting its internalization in lung cancer. Nat Commun. 2017;8:1182 pubmed publisher

Halim L, Romano M, McGregor R, Correa I, Pavlidis P, Grageda N, et al. An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment. Cell Rep. 2017;20:757-770 pubmed publisher

Bak R, Porteus M. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors. Cell Rep. 2017;20:750-756 pubmed publisher

Horii M, Li Y, Wakeland A, Pizzo D, Nelson K, Sabatini K, et al. Human pluripotent stem cells as a model of trophoblast differentiation in both normal development and disease. Proc Natl Acad Sci U S A. 2016;113:E3882-91 pubmed publisher

Okita R, Wolf D, Yasuda K, Maeda A, Yukawa T, Saisho S, et al. Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells. PLoS ONE. 2015;10:e0139809 pubmed publisher

Dong A, Wodziak D, Lowe A. Epidermal growth factor receptor (EGFR) signaling requires a specific endoplasmic reticulum thioredoxin for the post-translational control of receptor presentation to the cell surface. J Biol Chem. 2015;290:8016-27 pubmed publisher

Pasternack J, Domogauer J, Khullar A, Akudugu J, Howell R. The advantage of antibody cocktails for targeted alpha therapy depends on specific activity. J Nucl Med. 2014;55:2012-9 pubmed publisher

Li Y, Moretto Zita M, Soncin F, Wakeland A, Wolfe L, Leon Garcia S, et al. BMP4-directed trophoblast differentiation of human embryonic stem cells is mediated through a ?Np63+ cytotrophoblast stem cell state. Development. 2013;140:3965-76 pubmed publisher